An Emerging Markets News Commentary
ORLANDO, Fla., March 24, 2020 (GLOBE NEWSWIRE) — Bright and early Monday morning, Hoth Therapeutics, Inc. (NASDAQ: HOTH) released news that the Company had entered into a joint venture agreement with its joint venture partner, Voltron Therapeutics, Inc., for the “Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19).”
Bay Street News